We are live on ! Find out more
DVAX

Dynavax Technologies

Delisted

DVAX was delisted on the 9th of February, 2026.

122 hedge funds and large institutions have $331M invested in Dynavax Technologies in 2016 Q3 according to their latest regulatory filings, with 25 funds opening new positions, 41 increasing their positions, 29 reducing their positions, and 24 closing their positions.

New
Increased
Maintained
Reduced
Closed

100% more call options, than puts

Call options by funds: $55.3M | Put options by funds: $27.6M

41% more repeat investments, than reductions

Existing positions increased: 41 | Existing positions reduced: 29

4% more first-time investments, than exits

New positions opened: 25 | Existing positions closed: 24

1% more funds holding

Funds holding: 121122 (+1)

25% less funds holding in top 10

Funds holding in top 10: 43 (-1)

30% less capital invested

Capital invested by funds: $470M → $331M (-$139M)

Holders
122
Holders Change
+1
Holders Change %
+0.83%
% of All Funds
3.25%
Holding in Top 10
3
Holding in Top 10 Change
-1
Holding in Top 10 Change %
-25%
% of All Funds
0.08%
New
25
Increased
41
Reduced
29
Closed
24
Calls
$55.3M
Puts
$27.6M
Net Calls
+$27.7M
Net Calls Change
-$1.16M
Name Holding Trade Value Shares
Change
Change in
Stake
Tudor Investment Corp
76
Tudor Investment Corp
Connecticut
$238K +$326K +22,654 New
AIG
77
American International Group
New York
$235K +$489 +34 +0.2%
HHMI
78
Howard Hughes Medical Institute
Maryland
$224K
BA
79
BlackRock Advisors
Delaware
$215K +$22.1K +1,537 +8%
TI
80
Trexquant Investment
Connecticut
$213K -$67.6K -4,705 -19%
Royal Bank of Canada
81
Royal Bank of Canada
Ontario, Canada
$204K
AA
82
Ancora Advisors
Ohio
$189K +$259K +18,000 New
VEA
83
Virtus ETF Advisers
New York
$181K
SSA
84
Schonfeld Strategic Advisors
New York
$179K +$245K +17,070 New
RJFSA
85
Raymond James Financial Services Advisors
Florida
$172K +$235K +16,382 New
State Board of Administration of Florida Retirement System
86
State Board of Administration of Florida Retirement System
Florida
$171K +$6.04K +420 +3%
BG
87
BlackRock Group
United Kingdom
$162K -$16.4K -1,143 -7%
Wells Fargo
88
Wells Fargo
California
$152K +$8.09K +563 +4%
Squarepoint
89
Squarepoint
New York
$152K +$208K +14,451 New
GCP
90
GSA Capital Partners
United Kingdom
$149K +$204K +14,213 New
California Public Employees Retirement System
91
California Public Employees Retirement System
California
$139K -$15.8K -1,100 -8%
SG Americas Securities
92
SG Americas Securities
New York
$125K +$171K +11,904 New
TSS
93
Two Sigma Securities
New York
$115K +$158K +10,974 New
RJA
94
Raymond James & Associates
Florida
$113K +$155K +10,812 New
CG
95
Cutler Group
California
$108K -$21.5K -1,493 -13%
CSS
96
Cubist Systematic Strategies
Connecticut
$108K +$144K +10,034 +3,982%
CI
97
Cowen Inc
New York
$105K +$144K +10,000 New
RG
98
Rathbones Group
United Kingdom
$105K +$144K +10,000 New
QT
99
Quantbot Technologies
New York
$102K +$141K +9,788 New
Legal & General Group
100
Legal & General Group
United Kingdom
$59K -$6.67K -464 -7%

DVAX Hedge Fund Activity: Q3 2016 in Review

122 of the 3,749 institutional investors tracked by Wall St. Rank reported a position in Dynavax Technologies (DVAX) for Q3 2016, worth a combined $331M — down 30% from $470M a quarter earlier.

Buyers outnumbered sellers: 25 funds opened new DVAX positions and 24 closed out — a net gain of 1 holder — while 41 added to existing stakes and 29 trimmed.

The largest buyer was William Blair & Company, adding an estimated $19.6M. The largest seller was OrbiMed, exiting entirely with an estimated $35M sold.

  • 122 institutional investors held Dynavax Technologies (DVAX) as of Q3 2016, up from 121 in Q2 2016.
  • Funds reported $331M of Dynavax Technologies stock for Q3 2016, down 30% quarter-over-quarter.
  • 25 funds opened new Dynavax Technologies positions in Q3 2016 and 24 closed out, a net change of +1 holder.
  • The largest Dynavax Technologies buyer in Q3 2016 was William Blair & Company, an estimated $19.6M added.
  • The largest Dynavax Technologies seller in Q3 2016 was OrbiMed, an estimated $35M sold.

Based on aggregated 13F filings for Q3 2016.